Corrigendum to “Dolutegravir-based antiretroviral therapy in a severely overweight child with a multi-drug resistant human immunodeficiency virus infection. A case report and review” [New Microbes New Infect] 6 (2015) 1–4]

The authors regret that in the original version of the article, for all drugs dosages that are written as ‘four time a day’ should be written as ‘once a day’ (4 time a day = qid/1 time a day = qd).

The authors would like to apologise for any inconvenience caused.